Enhanced Genomics Jun 11 2025 Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced the appointment of Dietrich Stephan, Ph.D. as Chair of the Board of Directors. In this role, Dr. Stephan will lead the management team in implementing the Company’s strategic plans, including driving expansion of its internal target identification pipeline